Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

McMaster University

$25,000.00

Development of an in-vitro patient-specific diagnostic simulator for vascular diseases and their interventions

FY 2022-23

Summary
Cardiovascular disease is expected to remain the leading cause of death by 2030 globally. In Canada, one in every four deaths is a result of cardiovascular disease and cardiovascular disease costs the Canadian economy more than $22 billion annually. Because the prevalence of cardiovascular disease increases with age, with the Canadian aging population, the negative impact of cardiovascular disease on the Canadian economy will increasingly grow. Diagnosis is a significant and repeated contributor to cardiovascular disease costs. In this project, a rapid computational tool for low-cost cardiovascular disease diagnosis is developed.This project indeed saves Canadian lives, creates jobs, and brings economic growth to Canada. This project enables the development of: (1) a rapid computational tool for low-cost cardiovascular disease diagnosis; (2) a predictive tool for planning clinical interventions at no risk to the patients. The tool will predict the effects of intervention scenarios on the cardiovascular system's function of each patient before performing an irreversible procedure on the body. Such a predictive tool is in high demand worldwide to guide personalized interventions; (3) a regulatory medical-device testing machine. This machine can serve the testing needs of medical-device companies by making it possible to perform many important in vivo evaluation routines in vitro and will significantly reduce the need for animal studies and human trials so it can significantly speed up the device approval process and reduce the time-to-market and cost-to-market for new medical devices. This machine, therefore, will increase Canada's share in the medical devices market as the manufacturers of these devices need to perform regulatory design and durability tests to receive approvals before releasing their medical devices to the market.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
577535-2022
Name nom
Keshavarz Motamed, Zahra Z
Department département
Mechanical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
Development of an in-vitro patient-specific diagnostic simulator for vascular diseases and their interventions
Application summary
Cardiovascular disease is expected to remain the leading cause of death by 2030 globally. In Canada, one in every four deaths is a result of cardiovascular disease and cardiovascular disease costs the Canadian economy more than $22 billion annually. Because the prevalence of cardiovascular disease increases with age, with the Canadian aging population, the negative impact of cardiovascular disease on the Canadian economy will increasingly grow. Diagnosis is a significant and repeated contributor to cardiovascular disease costs. In this project, a rapid computational tool for low-cost cardiovascular disease diagnosis is developed.This project indeed saves Canadian lives, creates jobs, and brings economic growth to Canada. This project enables the development of: (1) a rapid computational tool for low-cost cardiovascular disease diagnosis; (2) a predictive tool for planning clinical interventions at no risk to the patients. The tool will predict the effects of intervention scenarios on the cardiovascular system's function of each patient before performing an irreversible procedure on the body. Such a predictive tool is in high demand worldwide to guide personalized interventions; (3) a regulatory medical-device testing machine. This machine can serve the testing needs of medical-device companies by making it possible to perform many important in vivo evaluation routines in vitro and will significantly reduce the need for animal studies and human trials so it can significantly speed up the device approval process and reduce the time-to-market and cost-to-market for new medical devices. This machine, therefore, will increase Canada's share in the medical devices market as the manufacturers of these devices need to perform regulatory design and durability tests to receive approvals before releasing their medical devices to the market.